Adithya Gopinath

731 total citations
21 papers, 495 citations indexed

About

Adithya Gopinath is a scholar working on Cellular and Molecular Neuroscience, Immunology and Neurology. According to data from OpenAlex, Adithya Gopinath has authored 21 papers receiving a total of 495 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cellular and Molecular Neuroscience, 8 papers in Immunology and 7 papers in Neurology. Recurrent topics in Adithya Gopinath's work include Neuroinflammation and Neurodegeneration Mechanisms (7 papers), Tryptophan and brain disorders (6 papers) and Parkinson's Disease Mechanisms and Treatments (4 papers). Adithya Gopinath is often cited by papers focused on Neuroinflammation and Neurodegeneration Mechanisms (7 papers), Tryptophan and brain disorders (6 papers) and Parkinson's Disease Mechanisms and Treatments (4 papers). Adithya Gopinath collaborates with scholars based in United States, United Kingdom and Denmark. Adithya Gopinath's co-authors include Habibeh Khoshbouei, Joseph Flores‐Toro, Rakesh K. Jain, Israel Charo, Thomas J. Schall, Meenal Datta, Duane A. Mitchell, Defang Luo, Jeffrey K. Harrison and Rajinder Singh and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Brain.

In The Last Decade

Adithya Gopinath

17 papers receiving 490 citations

Peers

Countries citing papers authored by Adithya Gopinath

Since Specialization

Citations

This map shows the geographic impact of Adithya Gopinath's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adithya Gopinath with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adithya Gopinath more than expected).

Fields of papers citing papers by Adithya Gopinath

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adithya Gopinath. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adithya Gopinath. The network helps show where Adithya Gopinath may publish in the future.

Co-authorship network of co-authors of Adithya Gopinath

This figure shows the co-authorship network connecting the top 25 collaborators of Adithya Gopinath. A scholar is included among the top collaborators of Adithya Gopinath based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adithya Gopinath. Adithya Gopinath is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	TNF-α signaling mediates the dopaminergic effects of methamphetamine by stimulating dopamine transporters and L-type Ca ²⁺ channels 2025 ·Science Signaling ·(unknown), Marcelo Febo, Adriaan W. Bruijnzeel, (unknown), Adithya Gopinath, (unknown), (unknown), Habibeh Khoshbouei	0
2	Parkinson’s paradox: alpha-synuclein’s selective strike on SNc dopamine neurons over VTA 2025 ·npj Parkinson s Disease ·Liem Phan, Douglas R. Miller, Adithya Gopinath, Min Lin, Edmund J. Miller, (unknown), Sophie Quintin, David N. Borg, (unknown), Alexander Newman, Zachary A. Sorrentino, James R. Seibold, Brian L. Hoh, Benoit I. Giasson, Habibeh Khoshbouei	1
3	Immunophenotyping Tracks Motor Progression in Parkinson’s Disease Associated with a TH Mutation 2024 ·Journal of Parkinson s Disease ·Adithya Gopinath, Adolfo Ramirez–Zamora, (unknown), (unknown), (unknown), (unknown), (unknown), Jordan Follett, Camille Swartz, (unknown), (unknown), Matthew J. Farrer, Michael S. Okun, Habibeh Khoshbouei	0
4	Development of a Fluorescently Labeled Ligand for Rapid Detection of DAT in Human and Mouse Peripheral Blood Monocytes 2024 ·SHILAP Revista de lepidopterología ·(unknown), Adithya Gopinath, (unknown), Habibeh Khoshbouei, Amy Hauck Newman	2
5	Methamphetamine induces a low dopamine transporter expressing state without altering the total number of peripheral immune cells 2023 ·Basic & Clinical Pharmacology & Toxicology ·Adithya Gopinath, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Luis R. Martinez, Habibeh Khoshbouei	5
6	Who Knew? Dopamine Transporter Activity Is Critical in Innate and Adaptive Immune Responses 2023 ·Cells ·Adithya Gopinath, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Brian K. Law, Nikhil M. Urs, Habibeh Khoshbouei	18
7	Dopamine transporter activity regulates neuroimmune communication 2023 ·Journal of Pharmacology and Experimental Therapeutics ·Adithya Gopinath, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Michael S. Okun, Habibeh Khoshbouei	0
8	Choroid plexus mis-splicing and altered cerebrospinal fluid composition in myotonic dystrophy type 1 2023 ·Brain ·Curtis A. Nutter, (unknown), (unknown), Johanna Hamel, (unknown), (unknown), (unknown), (unknown), Adithya Gopinath, (unknown), Łukasz J. Sznajder, Eric T. Wang, Laura P.W. Ranum, Habibeh Khoshbouei, John Day, Jacinda B. Sampson, Stefan Prokop, Maurice S. Swanson	6
9	DAT and TH expression marks human Parkinson’s disease in peripheral immune cells 2022 ·npj Parkinson s Disease ·Adithya Gopinath, (unknown), (unknown), (unknown), (unknown), (unknown), Gerry Shaw, (unknown), Leila Saadatpour, Aryn H. Gittis, Adolfo Ramirez–Zamora, Michael S. Okun, Wolfgang J. Streit, Parastoo Hashemi, Habibeh Khoshbouei	28
10	Functional characterization of the biogenic amine transporters on human macrophages 2022 ·JCI Insight ·(unknown), Adithya Gopinath, (unknown), (unknown), (unknown), (unknown), (unknown), Stephanie Matt, (unknown), (unknown), (unknown), Andria Doty, Adolfo Ramirez–Zamora, Long Yan, Peter J. Gaskill, Wolfgang J. Streit, Michael S. Okun, Habibeh Khoshbouei	19
11	The complex role of inflammation and gliotransmitters in Parkinson's disease 2022 ·Neurobiology of Disease ·Adithya Gopinath, (unknown), (unknown), Malú G. Tansey, Habibeh Khoshbouei	27
12	α-Synuclein-induced dysregulation of neuronal activity contributes to murine dopamine neuron vulnerability 2021 ·npj Parkinson s Disease ·(unknown), Douglas R. Miller, Min Lin, Adithya Gopinath, Fatemeh Shaerzadeh, Sharonda Harris, Zachary A. Sorrentino, (unknown), (unknown), (unknown), (unknown), Joseph J. Lebowitz, (unknown), (unknown), (unknown), Nikhil M. Urs, Benoit I. Giasson, Habibeh Khoshbouei	28
13	Methamphetamine Dysregulation of the Central Nervous System and Peripheral Immunity 2021 ·Journal of Pharmacology and Experimental Therapeutics ·Douglas R. Miller, (unknown), Adithya Gopinath, Luis R. Martinez, Habibeh Khoshbouei	35
14	Author Correction: TNFα increases tyrosine hydroxylase expression in human monocytes 2021 ·npj Parkinson s Disease ·Adithya Gopinath, (unknown), (unknown), Gerry Shaw, Anthony Collins, Douglas R. Miller, (unknown), (unknown), Malú G. Tansey, (unknown), Irina Madorsky, Adolfo Ramirez–Zamora, Michael S. Okun, Wolfgang J. Streit, Habibeh Khoshbouei	1
15	TNFα increases tyrosine hydroxylase expression in human monocytes 2021 ·npj Parkinson s Disease ·Adithya Gopinath, (unknown), (unknown), Gerry Shaw, Anthony Collins, Douglas R. Miller, (unknown), (unknown), Malú G. Tansey, (unknown), Irina Madorsky, Adolfo Ramirez–Zamora, Michael S. Okun, Wolfgang J. Streit, Habibeh Khoshbouei	12
16	Microglia and Other Myeloid Cells in Central Nervous System Health and Disease 2020 ·Journal of Pharmacology and Experimental Therapeutics ·Adithya Gopinath, Anthony Collins, Habibeh Khoshbouei, Wolfgang R. Streit	28
17	A novel approach to study markers of dopamine signaling in peripheral immune cells 2019 ·Journal of Immunological Methods ·Adithya Gopinath, Andria Doty, (unknown), (unknown), (unknown), Leila Saadatpour, Kaustuv Saha, Gerry Shaw, Adolfo Ramirez–Zamora, Michael S. Okun, Wolfgang J. Streit, Habibeh Khoshbouei	16
18	CCR2 inhibition reduces tumor myeloid cells and unmasks a checkpoint inhibitor effect to slow progression of resistant murine gliomas 2019 ·Proceedings of the National Academy of Sciences ·Joseph Flores‐Toro, Defang Luo, Adithya Gopinath, Matthew R. Sarkisian, James J. Campbell, Israel Charo, Rajinder Singh, Thomas J. Schall, Meenal Datta, Rakesh K. Jain, Duane A. Mitchell, Jeffrey K. Harrison	244
19	IMMU-09. DISRUPTION OF THE CCL2-CCR2 AXIS AUGMENTS THE EFFECTS OF IMMUNE CHECKPOINT INHIBITORS TO SLOW PROGRESSION OF GLIOMAS 2017 ·Neuro-Oncology ·Adithya Gopinath, Defang Luo, Matthew R. Sarkisian, James J. Campbell, Israel Charo, Thomas J. Schall, Jeffrey K. Harrison	1
20	Gastric emptying of hexose sugars: role of osmolality, molecular structure and the CCK1 receptor 2010 ·Neurogastroenterology & Motility ·Tanya J. Little, Adithya Gopinath, (unknown), (unknown), (unknown), Mauro D’Amato, John McLaughlin, David G. Thompson	24

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact